Jones Financial Companies
BLTE

Jones Financial Companies’s Belite Bio BLTE Stock Holding History

Jones Financial Companies’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$912 Hold
6
– – ﹤0.01% 4367
2025
Q4 		$960 Buy
+6
New +$711 ﹤0.01% 4026

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jones Financial Companies's BLTE Position: Q1 2026 in Review

Jones Financial Companies held its Belite Bio (BLTE) position steady in Q1 2026 at 6 shares worth $912. The position accounts for ﹤0.01% of the portfolio, ranked #4367.

Jones Financial Companies first reported a position in BLTE in Q4 2025 and has held it in 2 quarters since. The position peaked at $960 in Q4 2025. 75 funds tracked by Wall St. Rank hold BLTE as of Q1 2026.

  • Jones Financial Companies held 6 shares of Belite Bio worth $912 as of Q1 2026.
  • Jones Financial Companies left its Belite Bio share count unchanged in Q1 2026.
  • Belite Bio made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4367 holding.
  • Jones Financial Companies first reported a position in Belite Bio in Q4 2025 and has held it in 2 quarters since.
  • Jones Financial Companies's Belite Bio position peaked at $960 in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Belite Bio as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.